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Perinatal inflammation is known to contribute to neurodevelopmental diseases. Animal models of peri-
natal inflammation have revealed that the inflammatory response within the brain is age dependent, but
the regulators of this variation remain unclear. In the adult, the peripheral acute phase response (APR) is
known to be pivotal in the downstream recruitment of leukocytes to the injured brain. The relationship
between perinatal brain injury and the APR has not been established. Here, we generated focal inflamma-
tion in the brain using interleukin (IL)-1b at postnatal day (P)7, P14, P21 and P56 and studied both the
central nervous system (CNS) and hepatic inflammatory responses at 4 h. We found that there is a signif-
icant window of susceptibility in mice at P14, when compared to mice at P7, P21 and P56. This was
reflected in increased neutrophil recruitment to the CNS, as well as an increase in blood–brain barrier
permeability. To investigate phenomena underlying this window of susceptibility, we performed a dose
response of IL-1b. Whilst induction of endogenous IL-1b or intercellular adhesion molecule (ICAM)-1 in
the brain and induction of a hepatic APR were dose dependent, the recruitment of neutrophils and asso-
ciated blood–brain barrier breakdown was inversely proportional. Furthermore, in contrast to adult ani-
mals, an additional peripheral challenge (intravenous IL-1b) reduced the degree of CNS inflammation,
rather than exacerbating it. Together these results suggest a unique window of susceptibility to CNS
injury, meaning that suppressing systemic inflammation after brain injury may exacerbate the damage
caused, in an age-dependent manner.
 2018 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Neuroinflammation is implicated in the aetiology of neurode-
velopmental disorders, such as autism, schizophrenia (Bayer
et al., 1999; Bloomfield et al., 2016; Estes and McAllister, 2015;
Fillman et al., 2013; Trépanier et al., 2016; Vargas et al., 2005)
and cerebral palsy (Kadhim et al., 2003, 2001; Mallard et al.,2014). The impact of inflammation on development appears to
be highly dependent on the timing of the challenge; for instance,
autism and schizophrenia have been associated with infection dur-
ing the first and second trimester, while vulnerability to cerebral
palsy was highest in the last trimester and early postnatal period
(Atladóttir et al., 2010; Brown et al., 2004; Dubowitz et al., 1985;
Mednick et al., 1988).
Inflammatory challenges in rodents at different time points
during development have revealed that there are striking differ-
ences in the nature of the cellular and molecular responses
(Lawson and Perry, 1995; Meyer et al., 2006; Straley et al., 2017).
For example, a window of susceptibility exists in rats at three-
weeks postpartum, when the generation of a focal inflammatory
lesion in the brain results in increased leukocyte recruitment and
blood–brain barrier breakdown, which is not observed eitherdow of
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immune activation by the intraperitoneal injection of lipopolysac-
charide (LPS) has also been shown to transiently increased blood–
brain barrier permeability in the periventricular white matter
tracts during the first postnatal week in rats (Stolp et al., 2005)
and an intraperitoneal injection of LPS followed by hypoxia–is-
chemia was shown to increase blood–brain barrier permeability
at postnatal day (P)12 but not at P1 in Lewis rats (Brochu et al.,
2011). Both studies from Anthony et al. (1997) and Brochu et al.
(2011) have correlated blood–brain barrier permeability with the
recruitment of neutrophils to the brain. These variations in the
inflammatory response during development may alter cortical
development and have a lasting impact on behaviour (Stolp
et al., 2011a,b).
In adults, focal cerebral inflammation (Campbell et al., 2005,
2003; Wilcockson et al., 2002), traumatic brain injury (Villapol
et al., 2015) and cerebral ischemia (Chapman et al., 2009) in
rodents have been shown to induce the hepatic acute phase
response (APR) characterized by the expression of cytokines and
chemokines, other acute phase proteins such as serum amyloid
A, and the recruitment of neutrophils and macrophages.
Campbell et al. (2003) observed that an intracerebral injection of
interleukin (IL)-1b induced the production and release of C-X-C
motif ligand (CXCL)-1 by the liver and the recruitment of neu-
trophils to the liver, blood and brain in a dose-dependent manner.
The hepatic APR functions to eliminate the inflammatory stimuli,
attenuate local inflammation, and promote tissue repair and regen-
eration (Anthony et al., 2012; Anthony and Couch, 2014). However,
by recruiting and priming leukocytes to the site of injury in the
central nervous system (CNS), the APR may also contribute to fur-
ther damage in the brain. Systemic inflammation has been shown
to exacerbate focal neuroinflammatory injury in the adult. A num-
ber of rodent and human studies have demonstrated a positive cor-
relation between the magnitude of the APR and brain injury
(Acalovschi et al., 2003; Campbell et al., 2003; Di Napoli et al.,
2005; Smith et al., 2006, 2004; Vila et al., 2000; Villapol, 2016).
In the perinatal period, an altered hepatic APR has also been
reported following hypoxic-ischemic encephalopathy in rats,
which was characterized by upregulation of CXCL-1 and downreg-
ulation of tumour necrosis factor (TNF), IL-1b and CCL-2 (Bonestroo
et al., 2013). However, the nature of this response, and how it
affects the evolution of the central injury, is still unclear. It is likely
that, as in adult, the hepatic APR may impact the magnitude of the
CNS immune response and subsequent secondary injury.
In this study, we use a well-established model of focal intrac-
erebral inflammation to study the role of the hepatic APR in mod-
ulating the brain response to acute inflammation during postnatal
development. The intrastriatal injection of IL-1b generates a repro-
ducible focal inflammatory lesion which is accompanied by de
novo production of cytokines, the activation of microglia and local
endothelial cells in the absence of acute neuronal cell death
(Campbell et al., 2007a,b; Docagne et al., 2005; van Kasteren
et al., 2009). The local cellular response to the inflammatory chal-
lenge is conspicuous from 4 h to 7 days post injection (Docagne
et al., 2005). Here we show that susceptibility of the brain to focal
inflammation varies with age, and that contrary to expectations,
the CNS response is inversely proportional to the APR during the
window of susceptibility.
2. Materials and methods
2.1. Animals
C57Bl/6 mice were used at postnatal day (P)7, P14, P21 and P56.
These ages were selected based on a previous publication in ratsPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.(Anthony et al., 1997), and on preliminary data from our own lab
in mice, showing a mid-to-late postnatal window of susceptibility
to an inflammatory challenge that is likely to be related to the
increased susceptibility of children to CNS infections and injury
(Catroppa et al., 2008; Duval et al., 2008; Semple et al., 2013). Mice
were obtained from Harlan, UK, and acclimatised for at least 3 days
to the local environment prior to experimentation. Animals were
housed in specific pathogen-free facilities under a standard light/-
dark cycle with food and water ad libitum. All animal procedures
were conducted in accordance with the U.K. Animals (Scientific
Procedures) Act, 1986 and associated guidelines, EU Directive
2010/63/EU for animal experiments (PPL: 30/3076). Both male
and female pups were used in these experiments; no effect of
sex was identified in any response measured. Litters were split
between experimental groups to limit any effect of maternal care
on the experiments. The number of animals used in each group
studied can be found in figure legends.
2.2. Administration of IL-1b
Animals were anaesthetised with 2–3% isoflurane in oxygen.
Stereotaxic surgery was performed under an operating microscope,
as previously described (Couch et al., 2014). The top of the head
was shaved and positioned in a stereotaxic frame. The skull was
exposed and a small hole made with dental drill burr (Bregma: A
nterior/Posterior + 0.5 mm; Medial/Lateral + 1 mm (P7, P14), 1.5
mm (P21) or 1.8 mm (P56); Dorsal/Ventral  1.7 mm (P7) or 2
mm (P14, P21, P56). Rat recombinant IL-1b (rrIL-1b, 501-RL/CF;
2 ng/ml, 20 ng/ml or 200 ng/ml; R&D Systems, UK) or vehicle (0.9%
saline) were injected into the left striatum with finely-drawn glass
microcapillary needle (0.5 ml over a period of 5 min), and the
wound was closed using surgical clips. All coordinates were
defined using dye injections in preliminary experiments. In a
cohort of mice at P14, saline or 100 ng of rrIL-1b (50 ml) was
injected into the tail vein immediately after the intracerebral injec-
tion outlined above. This dose of IL-1b was chosen based on previ-
ous results showing that 100 ng of IL-1b induces the hepatic
expression of factor nuclear kappa B (NFkB), which regulates neu-
trophil recruitment to the injured brain, at a similar level to the
focal intracerebral injection of IL-1b (Campbell et al., 2008). Ani-
mals recovered in a heated chamber before being returned to their
cage.
2.3. Tissue preparation
Two or four hours following intracerebral or intravenous injec-
tion of rrIL-1b or saline, mice were anaesthetized with pentobar-
bital (20% w/v pentobarbital sodium, i.p.; J M Loveridge Ltd, UK)
and then transcardially perfused with cold 0.9% saline with hep-
arin (Sigma, UK). Liver and striatum were frozen on dry ice for
mRNA extraction. The striatum was dissected into ipsilateral
(injected) and contralateral side from saline and IL-1b injected
animals, and the contralateral (right) side from naïve animals.
Alternately, mice were transcardially perfused fixed with 4%
paraformaldehyde (in 0.1 M phosphate buffer, pH 7.4) after 0.9%
saline with heparin (Sigma, UK). Brain and liver were collected
and immersed into 4% paraformaldehyde at 4 C for 24 h, before
cryoprotection in 30% sucrose (4 C) and subsequently embedded
in O.C.T. compound (CellPath, UK). Ten-micrometer-thick sections
were cut on a cryostat Leica CM1850 (Leica Microsystems, UK)
and mounted on gelatin-coated slides in a serial manner. Brain
sections were collected for the full extent of the injection site
and lesion, from approximately Bregma + 1.10 to  0.10, based
on The Mouse Brain in Stereotaxic Coordinates (Paxinos and
Franklin).nse protects the brain from focal inflammation during postnatal window of
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Frozen sections were dried (37 C, 15 min), quenched for
endogenous peroxidase activity (0.3% hydrogen peroxide in metha-
nol; Sigma, UK) and blocked for non-specific Fc-dependent binding
in 10% serum in phosphate-buffered saline (PBS). Endogenous bio-
tin in the liver was blocked using an avidin–biotin blocking kit
(Vector Laboratories, UK). Primary antibodies (laminin, 1:500,
Abcam ab7463; anti-neutrophil serum HB199, 1:1000, made in-
house, in rabbits) were incubated at 4 C overnight. Sections were
incubated in biotinylated secondary antibody for 2 h at room tem-
perature (Vector Laboratories, UK), followed by an avidin–biotin-
peroxidase solution (Vectastain Elite ABC, Vector Laboratories,
UK) for 1 h at room temperature and the reaction product detected
with diaminobenzidine hydrochloride (DAB, 0.5 mg/ml, Sigma, UK)
in 0.1 M phosphate buffer with 0.05% hydrogen peroxide, with PBS
washes (3x5min) between each step. Slides were counterstained
with cresyl violet (Acros Organics, Fisher Scientific, UK), dehy-
drated and cleared before permanent mounting with DPX medium.
Blood-brain barrier permeability was measured by determining
the extent of endogenous IgG in the brain. Tissue was incubated
with a biotinylated antibody against mouse IgG (Vector Laborato-
ries, UK). Double immunohistochemistry for neutrophils and lami-
nin was performed by two sequential immunohistochemistry
processes using two different peroxidase substracts: DAB (brown)
and VECTOR VIP (purple; Vector Laboratories, UK), respectively.
These were separated by an avidin/biotin blocking (Avidin/Biotin
blocking kit, Vector Laboratories, UK). A citrate buffer (10 mM
Citric Acid, 0.05% Tween 20, pH 6.0) antigen retrieval step was
added to the laminin staining protocol.
Cell counts were performed using a Leitz Laborlux S microscope
(Leica Biosystems, GE) under 40 magnification. Neutrophils were
randomly counted throughout the liver using a 10  10 eyepiece
grid that equated to an area of 0.063 mm2. The total number of
neutrophils in the parenchyma and/or vessels (either in the lumen
or attached to the vessel wall) in the injection site were counted in
the whole ipsilateral striatum of at least two coronal sections for
each brain, approximately 120 mm apart. The striatum was traced
under a Camera Lucida (4 magnification) attached to the micro-
scope. All tracings were scanned and the area was measured in
ImageJ. Calibration was performed with a 1 mm scale micrometer
slide in order to obtain the final number of cells per mm2 of
striatum.
To schematically represent neutrophil recruitment patterns in
the brain, a spatial map of neutrophil location was drawn using a
Camera Lucida attached to the light microscope from a coronal sec-
tion at Bregma + 0.5 mm through the injection site. Spatial maps
were superimposed onto coronal figure 27 from The Mouse Brain
in Stereotaxic Coordinates (Paxinos and Franklin) using Adobe
Photoshop.
2.5. Real-Time polymerase chain reaction (RT-qPCR)
mRNA was isolated using RNeasy mini kit (Qiagen, UK) follow-
ing manufacturer’s guidelines. The quantity and quality of mRNA
were assessed using a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, UK). mRNA was deemed to have sufficient purity when
the absorbance ratio at 260:280 was  2.0 and 260:230 ratio was
1.8–2.2. mRNA was converted to cDNA using nanoScript2TM reverse
transcript kit (Primerdesign, UK). Real-Time polymerase chain
reaction (RT-qPCR) was performed using a LightCycler 480 (Roche
Diagnostics, UK) and SBYR green mastermix (Primerdesign, UK).
Primers for intercellular adhesion molecule-1 (ICAM-1) were
obtained from Invitrogen and, primers for TNF were obtained from
Roche Life Science. The rest of the primers were obtained as cus-
tom designed real-time PCR assays from Primerdesign (IL-1b:Please cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.GCTATGGCAACTGTTCCTGAA, R: ACAGCCCAGGTCAAAGGTT; IL-6:
AATTCCAGAAACCGCTATGAAGT and ATCCTCTGTGAAGTCTCCTCTC;
TNF: TGCCTATGTCTCAGCCTCTTC and GAGGCCATTTGGGAACTTCT;
CXCL-2: CAGAAGTCATAGCCACTCTCAAG and AGCCTTGCCTTTGTT-
CAGTATC; CXCL-5: AAAGATTTCTGAGGACTCTGACC and
TTTTCTCATCAAAGCAGGGAGT; ICAM-1: CCCACGCTACCTCTGCTC
and GATGGATACCTGAGCATCACC). House-keeping genes were
selected by a GeNorm analysis using a representative set of brain
and liver samples (geNormPLUS 12 gene kit, Primerdesign, UK).
GeNorm allows the selection of one or more candidate reference
genes that are not affected by the experimental conditions and
constitutively expressed in all the samples. Zinc finger protein 91
(Zpf91) and cell division cycle 40 homolog (yeast, Cdc40) were
used as housekeeping genes for brain samples and, casein kinase
2, alpha prime polypeptide (Csnk2a2) and PAK1 interacting protein
1 (Pak1ip1) for liver samples. A relative quantification was per-
formed using DDCt analysis. The results were represented as fold
change from naïve (or other relevant controls, as stated in the
results) expression levels.
2.6. Statistics
Data are presented as mean ± standard error of the mean (SEM)
and considered statistically significant with a p < .05. Data were
analysed using one-way ANOVA with Tukey’s multiple comparison
test or two-way ANOVA with Bonferroni–Dunn post hoc test for
multiple groups where appropriate.3. Results
3.1. Neutrophil recruitment and increases in blood–brain barrier
permeability following intracerebral IL-1b are age-dependent
Focal inflammation in the brain was induced by injecting 1 ng
IL-1b into the left striatum of C57Bl/6 mice at P7, P14, P21 and
P58. Naïve and saline injected brains were used as controls. Neu-
trophil recruitment to the striatum was assessed 4 h after intrac-
erebral injection (Fig. 1). No neutrophils were observed in the
brain (blood vessels or parenchyma) of naïve or saline injected
mice. Following a 1 ng IL-1b injection into the brain, there was sig-
nificantly (p < .001) enhanced neutrophil recruitment at P14 (85 ±
21 cells/mm2), compared to P7 (23 ± 10 cells/mm2), P21 (13 ± 4 c
ells/mm2) or P56 (0.1 ± 0.1 cells/mm2, Fig. 1A, B and Supplemen-
tary Fig. 1). However, while there was a marked increase at P14
compared to the other early perinatal time points, the recruitment
at all perinatal ages was markedly increased compared to the
recruitment observed in the adult animals. In view of the age-
dependent changes in neutrophil recruitment to the brain, perme-
ability of the blood–brain barrier to endogenous IgG was also
assessed (Fig. 1C). In control brains, endogenous IgG could not be
detected macroscopically. However, injection of 1 ng IL-1b
increased blood–brain barrier permeability in the ipsilateral stria-
tum at P14, but not at other ages evaluated, or in the contralateral
striatum. These results indicate that injection of 1 ng IL-1b induced
an acute window of susceptibility at P14 in mice, which was char-
acterized by excessive recruitment of neutrophils to the injected
striatum and increased blood–brain barrier permeability to
endogenous IgG when compared to earlier and later stages of
development.
3.2. The window of susceptibility at P14 disappears with increasing
doses of intracerebral IL-1b
The relationship between the dose of IL-1b and the brain
inflammatory response were investigated at P14. Neutrophilnse protects the brain from focal inflammation during postnatal window of
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Fig. 1. Recruitment of neutrophils to brain parenchyma and permeability of the blood–brain barrier to endogenous IgG 4 h after focal inflammation during postnatal period.
Neutrophils were recruited to the site of the intracerebral IL-1b (1ng) injection as shown in representative spatial maps of neutrophil distribution in the brain (A).
Recruitment of neutrophils 4 h after the injection was highest at P14 (A, B) and they were found to enter the brain parenchyma as well as filling the vessel lumen.
Photomicrographs in (A) show neutrophils (brown; anti-neutrophil serum) and vessels (pink; laminin) within the striatal injection site (marked by red ‘x’ in the P7 spatial
map). Intracerebral injection of 1 ng IL-1b and subsequent neutrophil recruitment was associated with increased blood–brain barrier permeability to endogenous IgG at P14,
but not at P7, P21 and P56 as shown in the photomicrographs in (C). Scale bar = 50 mm. ***p < .001. ###p < .001 vs. all parenchyma values. P7: n = 4, P14: n = 5, P21: n = 4 and
P56: n = 3. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
4 I. Sá-Pereira et al. / Brain, Behavior, and Immunity xxx (2018) xxx–xxxrecruitment, blood–brain barrier permeability and gene expression
of IL-1b and ICAM-1 were examined in the brain 4 h after intrac-
erebral injection of 1 ng, 10 ng or 100 ng IL-1b and compared to
naïve and saline injected mice. Surprisingly, the number of neu-
trophils recruited to the ipsilateral striatum decreased with
increasing dose of IL-1b (Fig. 2A and C). In brains injected with 1
ng IL-1b, 37 ± 18 cells/mm2 were observed in vessels and 126 ± 4
1 cells/mm2 were found in the parenchyma (p < .05), indicating
that there is no parenchymal barrier to neutrophil recruitment atPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.this age (Fig. 2C). When 10 ng (14 ± 7 cells/mm2 in vessels and 1
0 ± 7 cells/mm2 in the parenchyma) or 100 ng IL-1b (5 ± 1/mm2
in vessels and 2 ± 0.2/mm2 in the parenchyma) was injected in
the striatum, not only were there fewer neutrophils present in
the brain, but a smaller percentage was able to cross the blood–
brain barrier. The response to 10 ng or 100 ng IL-1b was signifi-
cantly different to the 1 ng dose (p < .01) (Fig. 2C). This result also
correlated with the appearance of endogenous IgG in the brain.
After 4 h, IgG positive tissue was found in the ipsilateral striatumnse protects the brain from focal inflammation during postnatal window of
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Fig. 2. Effects of intracerebral injection of increasing doses of IL-1b on blood–brain barrier permeability, recruitment of neutrophils and expression of IL-1b and ICAM-1 at
P14. At 4 h an inverse relationship was found to be present between the intracerebral dose of IL-1b and subsequent neutrophil recruitment and blood–brain barrier
breakdown at P14 (A–C). (A) Representative spatial maps of neutrophil distribution in the brain and micrographs of tissue stained for neutrophils (brown; anti-neutrophil
serum) and vessels (pink; laminin), showing extensive neutrophil recruitment with 1 ng IL-1b, which reduced as the dose of IL-1b was increased. (B) Immunohistochemistry
for IgG shows entry of the endogenous protein into the brain tissue after the intracerebral injection of IL-1b at all doses, with the most staining observed following the 1 ng
dose of IL-1b. (C) Neutrophils were found in significantly larger numbers in both the vessel lumen and brain parenchyma in the 1 ng IL-1b group compared to higher doses.
(D) IL-1b and ICAM-1 mRNA expression levels were measured in the contralateral striatum of naïve mice and ipsilateral striatum of mice that received intracerebral injection
of saline or 1 ng, 10 ng or 100 ng IL-1b at P14. Data are represented as relative fold change from contralateral expression in naïve mice, and show a dose dependent increase in
brain gene expression with intracerebral IL-1b injection. Scale bar = 50 mm. *p < .05 and p < .001. ##p < .01 vs. all parenchyma values in C. n = 3 for immunohistochemistry
analysis; n = 4 for RT-qPCR. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
I. Sá-Pereira et al. / Brain, Behavior, and Immunity xxx (2018) xxx–xxx 5after 1 ng IL-1b injection, consistent with the data in Fig. 1. Com-
pared to the 1 ng dose, IgG extravasation was decreased when
10 ng IL-1b was injected in the brain, and almost no IgG staining
was visible after the 100 ng IL-1b injection (Fig. 2B). This unex-
pected dose response was further investigated at the other stages
of development. We found that, following intracerebral injection
of 100 ng IL-1b, there was a statistically significant difference in
the parenchymal neutrophil recruitment between the two IL-1bPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.doses administered. At P7, P14 and P21 there was a dose depen-
dent decrease in recruitment at all of these ages. However, at
P56 the higher dose of IL-1b resulted in a small, but statistically
significant increase in neutrophil recruitment (p < .01) (Supple-
mentary Fig. 2A). No increases in blood–brain barrier permeability
to endogenous IgG were observed at any age after intracerebral
injection of 100 ng IL-1b (not shown). To test if the absence of
the window of susceptibility at 4 h was the result of a change innse protects the brain from focal inflammation during postnatal window of
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recruitment of neutrophils to the brain was also examined 2 h after
intracerebral injection of 100 ng IL-1b at P7, P14 and P21. Few neu-
trophils were found in the brain, with no statistical significance
between both time points (2 and 4 h) and the responses in P7,
P14 and P21 animals. The lack of neutrophils at 2 h shows that
there is no window of susceptibility when compared to 1 ng IL-
1b dose at 4 h and suggests that high dose of IL-1b does not change
the kinetics of the response (Supplementary Fig. 2B). Therefore, all
further experiments were performed at 4 h.
The molecular response to IL-1b-induced inflammation in the
brain at P14 was assessed by measuring mRNA expression for IL-
1b and for ICAM-1 in the ipsilateral striatum at 4 h (Fig. 2D). In
adults, microinjection of IL-1b protein is known to induce further
expression of endogenous IL-1b (Blond et al., 2002). Injection of
vehicle did not generate an elevation in either transcript (4.57 ±
2.03 for IL-1b and 1.11 ± 0.12 for ICAM-1), compared to naïve
P14 brain (1.08 ± 0.06 for IL-1b and 1.24 ± 0.15 for ICAM-1).
Expression levels of IL-1b and ICAM-1 increased after stereotaxic
microinjection of 1 ng IL-1b (IL-1b: 278.30 ± 151.10; ICAM-1: 18.
80 ± 9.36), 10 ng IL-1b (IL-1b: 588.70 ± 27.42; ICAM-1: 52.67 ± 2.
10), or 100 ng (IL-1b: 729.80 ± 159.10; ICAM-1: 65.80 ± 2.99) into
the striatum. However, the increased expression was only statisti-
cally significant with the 10 ng (IL-1b: p < .001 vs. naïve, p < .05 vs.
saline; ICAM-1: p < .001 vs. naïve, saline and 1 ng) and 100 ng (IL-
1b: p < .001 vs. naïve and saline, p < .05 vs. 1 ng; ICAM-1: p < .001
vs. naïve, saline and 1 ng) doses. Thus, the molecular response is
dissociated from the cellular recruitment profile in the perinatal
brain.
3.3. Intracranial IL-1b induces a hepatic acute phase response at P14 in
a dose-dependent manner
Next, to determine whether the magnitude of the APR in the
liver might account for the atypical inflammatory response at
P14, the hepatic mRNA expression of the acute phase proteins IL-
6, TNF, ICAM-1, CXCL-2 and CXCL-5 was evaluated at 4 h. Intrac-
erebral injection of 1 ng IL-1b into the striatum of P14 animals
did not elicit an increase in the hepatic expression of any of the
transcripts examined. Injection of 10 ng IL-1b caused a 10-fold
increase in the expression of CXCL-2 and CXCL-5, however only
TNF expression was statistically different over baseline (saline: 0.
88 ± 0.24 and 10 ng: 2.03 ± 0.26, p < .05) following correction for
multiple comparisons. In contrast, the 100 ng IL-1b intracerebral
injection significantly increased the expression of all transcripts
(p < .001) (Fig. 3A). Furthermore, the number of neutrophils found
in the liver increased with increasing doses of intracerebral IL-1b
(Fig. 3B and C). The number of neutrophils was unchanged in saline
(62 ± 13 cells/mm2) animals or 1 ng IL-1b injected animals (64 ± 4
cells/mm2) compared to naïve (54 ± 6 cells/mm2) animals. How-
ever, intracerebral injection of either 10 ng IL-1b (150 ± 36 cells/
mm2, p < .01 vs. naïve and saline, p < .05 vs. 1 ng, p < .001 vs.
100 ng) or 100 ng IL-1b injection (319 ± 18/mm2, p < .001 vs. all
groups) resulted in a significant increase in the number of hepatic
neutrophils, a known feature of the hepatic response to brain
injury (Fig. 3C). The hepatic APR to 100 ng IL-1b was not restricted
to P14; similar increases in the expression of acute phase proteins
transcripts were observed at P7, P21 and P56 for IL-6, TNF, ICAM-1,
CXCL-2 and CXCL-5, and was also associated with the recruitment
of neutrophils (Supplementary Figs. 3 and 4). However, the magni-
tude of increase in the expression of the inflammatory mediators
and the number of neutrophils present in the liver 4 h after intrac-
erebral injection of 100 ng IL-1b was greatest in the youngest ani-
mals studied and decreased with age (statistically significant
following two-way ANOVA analysis with Bonferroni–Dunn post
hoc test with age and treatment as variables; SupplementaryPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.Table 1). There was also greater basal production of the acute
phase protein transcripts and basal neutrophil accumulation in
the younger animals (Supplementary Fig. 5).3.4. Activation of the hepatic acute phase response after intracerebral
injection of 1 ng IL-1b reduces signs of injury and neutrophil
recruitment to the brain
The previous results showed that there is an inverse relation-
ship between the severity of the cellular recruitment and blood–
brain barrier permeability, and the magnitude of the hepatic APR
at P14. This observation led us to hypothesise that activation of
the peripheral APR may actually inhibit neutrophil recruitment
to the brain and blood–brain barrier breakdown. In order to test
this hypothesis, an APR was induced with an intravenous injection
of 100 ng IL-1b immediately after intracerebral injection of 1 ng IL-
1b. Data from these animals was compared to mice that received
intracerebral injection of 1 ng IL-1b and intravenous injection of
saline or intracerebral injection of saline and intravenous injec-
tions of 100 ng IL-1b. The APR was significantly induced in the liv-
ers of mice that received 100 ng of intravenous IL-1b (Fig. 4A).
Interestingly, when this was coupled to an intracerebral injection
of 1 ng IL-1b, the magnitude of the response was reduced for all
transcripts (though only statistically significantly for CXCL-2/5, p
< .001). Thus, the 1 ng intracerebral injection seems to at least par-
tially inhibit the APR. Both 100 ng intravenous or intracerebral IL-
1b injections resulted in a significant accumulation of neutrophils
within the liver. By comparison, activation of the APR by intra-
venous IL-1b following the 1 ng intracerebral injection resulted
in a relative reduction in neutrophils (statistically different from
the response with high dose intracerebral IL-1b, p < .001) (Fig. 4B
and C).
The impact of the intravenous injection of 100 ng IL-1b on the
inflammatory response to intracerebral injection of 1 ng IL-1b on
the window of susceptibility at P14 was profound. The number
of neutrophils present in the striatum was significantly decreased
(4 ± 0.4 cells/mm2, p < .001) in the animals that received 100 ng
IL-1b intravenously after intracerebral injection of 1 ng IL-1b com-
pared to those that received an intracerebral injection of 1 ng IL-1b
followed by an intravenous injection of saline (162 ± 13 cells/m
m2). Indeed, the level of recruitment was reduced to the same
number induced by an intracerebral injection of 100 ng IL-1b (5
± 1 cells/mm2) (Fig. 5B and C). Blood-brain barrier permeability
to endogenous IgG was decreased in mice that received intra-
venous injection of 100 ng IL-1b when compared to those that
received intravenous injection of saline after 1 ng IL-1b injection
in the brain (Fig. 5D). Surprisingly, brain mRNA expression for IL-
1b and ICAM-1 in the striatum did not change after intravenous
injection of 100 ng IL-1b compared to mice that received intra-
venous injection of saline after 1 ng IL-1b injection in the brain
(Supplementary Fig. 6). Thus, the local production of inflammatory
mediators in the brain was unaffected by the peripheral challenge.4. Discussion
We have used a well-characterized model of brain inflamma-
tion (Anthony et al., 1997; Campbell et al., 2007a,b; Campbell
et al., 2003, 2002; Davis et al., 2005; Docagne et al., 2005; Sibson
et al., 2004; Wilcockson et al., 2002) to study the cross-talk
between brain and liver during postnatal period. Many studies
have shown that a stereotaxic injection of IL-1b into the striatum
of adult rodents induces the hepatic APR, which in turn, con-
tributes to the increased recruitment of neutrophils/monocytes
to the brain (Campbell et al., 2008, 2005, 2003; Wilcockson et al.,
2002). It has been established that the juvenile rodent brain isnse protects the brain from focal inflammation during postnatal window of
01.008
Fig. 3. Expression of inflammatory mediators and neutrophil recruitment in the liver 4 h after intracerebral injection of 1 ng, 10 ng or 100 ng IL-1b at P14. IL-6, TNF, ICAM-1,
CXCL-2 and CXCL-5 mRNA expression in the liver significantly increases following intracerebral injection of 100 ng of IL-1b, but not after the 1 ng dose (A). Data are
represented as relative fold change from expression levels of naïve mice P14. Neutrophil immunohistochemistry, counterstained with cresyl violet, in the liver shows
significant increases in the number of neutrophils per mm2 in tissue following the intracerebral injection of 10 ng and 100 ng IL-1b at P14. Scale bar = 50 mm. *p < .05, **p < .01
and ***p < .001. Naïve, 1 ng, 10 ng and 100 ng: n = 4, and saline: n = 8 for RT-qPCR; naïve: n = 7, saline: n = 6, 1 ng, 10 ng and 100 ng: n = 3 for immunohistochemistry analysis.
(For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
I. Sá-Pereira et al. / Brain, Behavior, and Immunity xxx (2018) xxx–xxx 7more susceptible to the intracerebral injection of IL-1b when com-
pared to adults and neonates, with substantial neutrophil recruit-
ment observed from 4 h and extending for days following focal
inflammation (Anthony et al., 1997; Blamire et al., 2000;
Campbell et al., 2007a,b).
Our results show that the activation of an APR in the perinatal
period inhibits, rather than augments, the response to acute brain
inflammation, and is counterintuitive when considered in light of
similar studies in adult animals. Overall, our findings suggest thatPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.the suppression of the peripheral inflammatory response after
perinatal brain injury might increase rather than decrease the
CNS inflammatory response and thus outcomes to injury.
4.1. Brain susceptibility to focal inflammation is age and dose-
dependent
In our study, a window of susceptibility to a low dose of IL-1b
(1ng) was found to peak at P14 and was not present at P7, P21nse protects the brain from focal inflammation during postnatal window of
01.008
Fig. 4. Activation of the acute phase response after intracerebral injection of 1 ng IL-1b at P14 by intravenous injection of 100 ng IL-1b. (A) Liver gene expression of
inflammatory cytokines and chemokines, IL-6, TNF, ICAM-1, CXCL-2 and CXCL-5 at 4 h in three different inflammatory paradigms: saline i.c. + 100 ng i.v., 1 ng i.c. + saline i.v.
and 1 ng i.c. + 100 ng i.v. Data are represented as relative fold change from expression levels in the 1 ng i.c. + saline i.v. group of animals. The intravenous administration of
100 ng IL-1b significantly increased expression of pro-inflammatory cytokines within the liver in comparison to the 1 ng IL-1b intracerebral injection alone. The combined
central and systemic IL-1b administration significantly reduced expression of CXCL-2 and CXCL-5 compared to systemic IL-1b alone. Neutrophil numbers in the liver of P14
mice that received an i.v. injection of 100 ng IL-1b or the combined treatment of i.v. 100 ng IL-1b and i.c. 1 ng IL-1bwere significantly higher than in animals that received an i.
c. injection of 1 ng IL-1b alone (B, C). The number of neutrophils found in the liver following the i.c. injection of 100 ng IL-1b alone was significantly higher than all other
groups (B, C). Scale bar = 50 mm. *p < .05, **p < .01 and ***p < .001. i.v.: intravenous, i.c.: intracerebral. saline i.c. + 100 ng i.v.: n = 3, 1 ng i.c. + saline i.v.: n = 8, 1 ng i.c./100 ng i.
v.: n = 8 and 100 ng i.c.: n = 6.
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Fig. 5. Modulation of neutrophil recruitment to the brain and blood–brain barrier
permeability by activation of the systemic acute phase response at P14. Combined
administration of i.c. 1 ng IL-1b and i.v. 100 ng IL-1b resulted in reduced neutrophil
recruitment to the brain at 4 h as shown by representative spatial maps of
neutrophil distribution in the brain (A) and photomicrographs of immunohisto-
chemistry for neutrophils (brown, anti-neutrophil serum counterstained with
cresyl violet) (B). The response was significantly less than when only 1 ng of IL-1b
was injected i.c., and was the same as when 100 ng of IL-1b was injected i.c. (C).
Representative pictures of blood–brain barrier permeability to endogenous IgG in
the 1 ng i.c. + saline or 100 ng i.v. groups show that the combined treatment also
reduces blood–brain barrier permeability (D). Scale bar = 50 mm. ***p < .001. i.v.:
intravenous, i.c.: intracerebral. 1 ng i.c./saline i.v.: n = 3, 1 ng i.c./100 ng i.v.: n = 4
and 100 ng i.c.: n = 6. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
I. Sá-Pereira et al. / Brain, Behavior, and Immunity xxx (2018) xxx–xxx 9or P56. In rats, a similar window has been described at P21 and was
considered to be associated with weaning or increased oligoden-
drocyte migration (Anthony et al., 1997). However, P14 in mice
is in the pre-weaning period and myelination peaks at P20 in bothPlease cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.rats and mice (Semple et al., 2013). Thus, the biology underpinning
this susceptible period must lie elsewhere. Lawson and Perry
(1995) also showed that LPS injected in the striatum of BALB/c
mice promoted an increased neutrophil recruitment to the brain
at P7 and not at P0. However, they did not study any further time
points and appear to have missed the P14 window. An LPS injec-
tion into Sprague-Dawley rats transiently increases blood–brain
barrier permeability in the first postnatal week (Stolp et al.,
2005). Increased neutrophil recruitment to the brain and altered
blood–brain barrier permeability has also been reported following
the combination of systemic LPS administration and central
hypoxic-ischemic injury at P12 but not at P1 in Lewis rats
(Brochu et al., 2011). While there are differences in the specific
timing of injury in these studies, likely due to the variation in
immunogen, species and study design, they all show the same phe-
nomena of a specific period of postnatal rodent development
which is acutely susceptible to altered blood–brain barrier perme-
ability as a result of inflammation.
It is our hypothesis that the increase in blood–brain barrier per-
meability to IgG at P14 is likely to be driven by the extensive neu-
trophil recruitment at this age and neutrophil depletion prevents
cytokine-induced blood–brain barrier breakdown. Anthony et al.
(1997) and Anthony et al. (1998) showed that the acute increase
in blood–brain barrier permeability produced at P21 in their rat
model (either with IL-1b or CXCL-1) was neutrophil-dependent,
and also associated with disruption of tight junction proteins
(Bolton et al., 1998). Neutrophils produce high levels of reactive
oxygen species that have been hypothesized to affect blood–brain
barrier integrity by activation of matrix metalloproteinases, oxida-
tive damage, modulation of tight junction proteins, cytoskeletal
reorganization, and induction of inflammatory mediators (Pun
et al., 2009). Matrix metalloproteinase 9 released by neutrophils
may also digest vessel basement membrane and/or extracellular
matrix and, consequently, contribute to the increased permeability
of the blood–brain barrier (Justicia et al., 2003; Moxon-Emre and
Schlichter, 2011; Rosell et al., 2008; Turner and Sharp, 2016), pro-
viding a potential mechanism for the neutrophil dependence of
this phenomenon.
Here, uniquely, we observed that the window of susceptibility
was dose dependent at P14, with significantly fewer neutrophils
being recruited in response to a rising dose of IL-1b and a reduction
in blood–brain barrier permeability at the 100 ng dose. However,
at P56 this dose resulted in a small, but significant increase in neu-
trophil recruitment, which did not coincide with a disruption of the
blood–brain barrier to endogenous IgG. The atypical nature of the
CNS response to pro-inflammatory challenges is widely reported
though the mechanism is still unknown (Campbell et al., 2007a,b).
4.2. The hepatic acute phase response to cerebral focal inflammation
Inflammation in the CNS is known to be followed by a periph-
eral APR that is coordinated mainly by the liver in adult rodents.
Stereotaxic injection of TNF (1000 ng) or IL-1b (1–1000 ng) in the
striatum of adult rats induced a hepatic APR, observed as an upreg-
ulation of the expression of chemokines and increased recruitment
of leukocytes, including neutrophils, 4 h after brain injection
(Campbell et al., 2005, Campbell et al., 2003). Stereotaxic injection
of IL-1b (1ng) in the striatum has been shown to induce the expres-
sion of acute phase proteins, including serum amyloid A and P, in
the liver 6 h after the injection in adult C57Bl/6 mice
(Wilcockson et al., 2002). The presence of inflammation in the
CNS has recently been shown to be transmitted to the periphery
via astrocyte-shed extracellular vesicles that activate the produc-
tion of acute phase proteins (Dickens et al., 2017).
In this study, the liver only produced a consistent and signifi-
cant APR following the injection of a high dose of IL-1b into thense protects the brain from focal inflammation during postnatal window of
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10 I. Sá-Pereira et al. / Brain, Behavior, and Immunity xxx (2018) xxx–xxxbrain. The response was seen at all ages examined, but there was
an age-specific difference in the magnitude of this response. Our
own experiments have shown that IL-1b injected into the brain
parenchyma does not leave the brain (Couch et al., 2017) and the
effect of the combination of the 1 ng intracerebral dose with a
100 ng intravenous dose compared to the 100 ng intravenous alone
suggests that simple leakage from the brain is not a factor here.
Indeed, the presence of 1 ng IL-1b in the brain seems to inhibit
the APR in these young animals and the local production of IL-1b
and ICAM-1 was unaffected by high circulating concentrations of
IL-1b.
The hepatic immune response in young animals is understud-
ied, adding to the novelty of the current work. Bonestroo et al.
(2013) have shown that cerebral hypoxia–ischemia caused a hep-
atic APR after 3 h in P7 rats characterized by upregulation of
CXCL-1 and downregulation of TNF, IL-1b and CCL-2. However, this
study did not explore the hepatic response in other postnatal ages
or in adults for a developmental comparison. The higher magni-
tude of the response in the younger animals observed in the pre-
sent study may be due to the innately elevated immune status of
the liver at these ages. In rodents, the liver undergoes an extensive
structural remodelling during the first four weeks after birth
(Alexander et al., 1997; Walthall et al., 2005), and the liver weight
increases as a result of the hepatic cell proliferation (Apte et al.,
2007; Behrens et al., 2002; Septer et al., 2012). TNF and IL-1 have
been shown to have an important role in hepatocytes growth dur-
ing this postnatal period by activating the NF-kB pathway
(Kinoshita and Miyajima, 2002; May and Ghosh, 1999). Thus, the
high expression of cytokines observed in our study may be
explained by their important role in liver development. Conse-
quently, the expression of cytokines in the liver decreases as this
organ maturates.
Increased expression of inflammatory mediators in the liver
early in postnatal period may also be directly linked to the
increased number of neutrophils. Neutrophils start to appear in
the liver at E15 and their number increases until P0, where they
remain proliferative in small distributed foci (Ayres-Silva et al.,
2011), which was also observed at P7 in our study. As a conse-
quence of liver maturation, mature or immature neutrophils leave
the liver as the environment ceases to be favourable (Ayres-Silva
et al., 2011; Kinoshita et al., 1999; Si-Tayeb et al., 2010), and neu-
trophils are largely absent from the adult healthy liver (Campbell
et al., 2003; Gregory et al., 1996). This may follow from a reduction
in hepatic chemokine production in the postnatal period, but as
neutrophils also express a number of CXC and CC chemokines it
is hard to determine whether the decrease is simply the result of
a reduction in cell number. It is unclear whether there is a direct
role of adhesion molecules, chemokines and neutrophils in liver
development, however, ICAM-1 and neutrophils were shown to
have a crucial role in liver regeneration after partial hepatectomy;
this may indicate its importance in liver growth during develop-
ment. Selzner et al. (2003) have suggested that the expression of
ICAM-1 in Kupffer cells and endothelial cells after partial hepatec-
tomy promotes neutrophils recruitment, which activates the
release of IL-6 and TNF by the Kupffer cells to promote regenera-
tion. As a result of these developmental phenomena, the postnatal
rodent liver may be primed to respond to inflammatory challenge.
4.3. Hepatic acute phase response can protect the brain from excessive
neutrophil recruitment and altered blood–brain barrier permeability
The local inflammatory response to intracerebral injection of
IL-1b was related to the dose administered, with the expression
of IL-1b and ICAM-1 in the brain positively correlated with the con-
centration of IL-1b injected. However, the neutrophil recruitment
and increased blood–brain barrier permeability to IgG was inver-Please cite this article in press as: Sá-Pereira, I., et al. Hepatic acute phase respo
susceptibility. Brain Behav. Immun. (2018), https://doi.org/10.1016/j.bbi.2018.sely affected and we wondered how this phenomenon, which
could not have been predicted from previous work in adult ani-
mals, might be related to the APR. The APR in the liver has been
correlated with the most severe cases of ischemic stroke and with
traumatic brain injury (Di Napoli et al., 2005; Smith et al., 2006;
Villapol, 2016). Previous studies have also shown that stereotaxic
injection of TNF or IL-1b in adult rats not only induced the APR
in the liver, but augmentation of the APR increased the recruitment
of leukocytes to the brain (Campbell et al., 2005, Campbell et al.,
2003). Consequently, Campbell et al. (2007a,b) showed that the
peripheral administration of etanercept, a competitive TNF inhibi-
tor, reduced the recruitment of neutrophils to an IL-1b-induced
focal inflammatory lesion in the brain via inhibition of the hepatic
APR in adult rats. Cerebral hypoxia–ischemia in P7 rats also
increased CXCL-1 expression in the liver and recruitment of neu-
trophils to the affected brain hemisphere (Bonestroo et al., 2013).
The timing and type of injury, as well as the animal species, may
underlie differences between the study of Bonestroo et al. (2013)
and our results. We have shown that while the number of neu-
trophils in the brain parenchyma decreased at P7, P14 and P21
with higher doses of IL-1b, at P56 there was an increase in neu-
trophils in the brain under the same circumstances. This suggests
that the observed inverse relationship between the severity of
brain cellular injury and the magnitude of the APR in the liver is
a specific developmental process. It is important to note that the
APR to an intracerebral injection of 100 ng IL-1b was much higher
at P14 than in the adult. This may be, in part, due to the increased
basal levels of inflammatory mediators at the early time points and
the increased number of basal neutrophils within the P14 naïve
liver. Thus, it seems that the liver may be primed at the time of
inflammation in the brain, and this ’head start’ in the activation
process may result in the increased magnitude of the APR at P14.
As a consequence, it is possible that the peripheral response then
overwhelms the inflammatory signals generated locally in the
brain and, thus, neutrophils are redirected to the liver and possibly
to other peripheral organs. In the adult, the APR is smaller and,
thus, may not out-compete the local injury signals in the brain that
recruit neutrophils (albeit a small number at acute time points).
The inverse relationship between magnitude of cellular inflam-
matory responses in the brain and liver observed at P14 also sug-
gests that activation of the APR may protect the brain from
excessive neutrophil recruitment and blood–brain barrier perme-
ability. Indeed, by injecting 100 ng IL-1b intravenous immediately
after stereotaxic injection of 1 ng IL-1b in the striatum of P14 mice,
the hepatic response was activated (increased neutrophils recruit-
ment and expression of inflammatory cytokines and chemokines)
and, consequently, eliminated almost all neutrophils from the
brain without inducing the expression of IL-1b and ICAM-1 in the
brain. These results support our hypothesis and showed, for the
first time, a protective role of the APR in the periphery to focal
inflammation during a specific window of development. Moreover,
they suggest that experimental activation of the peripheral
immune response may be used to reduce neonatal brain injury. It
is important to note that while these findings illuminate a novel
developmental response to inflammatory modulation, the out-
comes assessed are acute and long-term effects on both the inflam-
matory response and neuropathology need to be determined
before this work can be translated to a novel therapeutic approach.
Many anti-inflammatory therapies/drugs have been shown to
be beneficial for disorders in the adulthood, such as acute stroke
and traumatic brain injury, with an inflammatory component
(Bergold, 2016; Smith et al., 2015) while use of the steroid-based
anti-inflammatory agent dexamethasone in prenatal infants during
postnatal period has been associated with growth deficits at 2
years (Rijken et al., 2007) and decreases in cerebral cortical grey
matter volume at term time (Murphy et al., 2001) and later in lifense protects the brain from focal inflammation during postnatal window of
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inflammatory agents may not be universally protective, and that
a different, age-specific, therapeutic strategy needs to be explored
for these children. While this study does not directly model a
specific neuropathology, nor stage of human development, these
findings highlight the importance of matching therapeutic para-
digms to age and type of injury, and that treatment decisions
should not be applied on the basis of normal adult biology, a lesson
also important for the ageing brain (Campbell et al., 2007a,b).
In the future, it will be important to further study the relation-
ship between the brain and the hepatic inflammatory responses in
different inflammatory contexts. In particular, the effects of exper-
imental activation of the APR after inflammatory injuries in the
brain during development and in adults in order to confirm the
age-dependent effects of the hepatic immune response to brain
damage.
5. Conclusion
This study has demonstrated the importance of the interplay
between the brain and peripheral immune responses in defining
the magnitude of the acute inflammatory response in the brain
to focal inflammation during postnatal development in mice. The
data support the current view that susceptibility of the brain to
inflammation varies with age and that the peripheral immune
environment may define the overall response to injury. Activation
of the APR in the liver was shown to invert the window of suscep-
tibility in a mouse model of cerebral focal inflammation and, there-
fore, selective activation of the peripheral inflammatory response
may be a therapeutic option at specific developmental stages. This
work highlights the importance of selecting age-dependent ther-
apy for acute brain injury.
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